soul trial oral semaglutide cardiovascular outcomes results Reduces Events in People with Type 2 Diabetes with Atherosclerotic Cardiovascular and/or Chronic Kidney Disease: Primary From the Randomized soul trial oral semaglutide cardiovascular

Here are some of the benefits we are seeing: Improved blood sugar control Increased insulin sensitivity Lowered risk of nerve damage and kidney disease (this is most pertinent for diabetic patients) Lowered cholesterol levels Lowered blood pressure levels Decreased risk of stroke Decreased risk of cardiac events (like a heart attack or heart disease) Its important to point out that most of these benefits are a result of losing weight (we see these benefits after bariatric surgery as well) but some studies are showing positive benefits on their own (regardless of the amount of weight loss)

Examined for involvement in angiogenesis and vascular function in experimental systems

Some may interact with semaglutide, increasing the risk of fainting

It contributes to normal muscle function, energy metabolism, and electrolyte balance, all of which matter when youre exercising as well as changing the way you eat

Always disclose your full medical and medication history during your consultation

Ozempic is a Novo Nordisk drug